Extrawell Pharmaceutical Holdings Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Extrawell Pharmaceutical Holdings Limited with three other
pharmaceutical manufacturers in Asia:
FutureChem Co Ltd
of KOREA (SOUTH)
sales of 11.01 billion Korean Won [US$9.70 million]
Coral Laboratories Limited
(705.80 million Indian Rupees [US$9.52 million]
of which 100%
was Manufacturing & Sale of Pharmaceutical P), and
based in INDIA
(739.26 million Indian Rupees [US$9.97 million]
of which 69%
During the second
quarter of 2021, sales at Extrawell Pharmaceutical Holdings Limited totalled
This is a drop of 9.7%
from the HK$40.70 million in sales at the company during the second quarter in 2020.
During the year ended March of 2020, sales at
Extrawell Pharmaceutical Holdings Limited were HK$77.58 million (US$9.99 million).
decrease of 13.0%
versus 2019, when the company's sales were HK$89.22 million.